Meningococcal sepsis in pediatrics. Parameters associated with poor outcome;Sepsis meningocócica en pediatría. Parámetros asociados a mala evolución

Anales de Pediatria

Volumn 61, Issue 4, 2004, Pages 305-313

  Blanco Quiros A ^a,d   Casado Flores, J ^b   Nieto Moro, M ^b   Garrote Adrados, J A ^a,c   Arranz Sanz, E ^a   Asensio Anton J ^b  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^d UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Body weight; Leptin; Meningococcal infection; Mortality; Procalcitonin; Sepsis

Indexed keywords

ADRENALIN; C REACTIVE PROTEIN; DOBUTAMINE; DOPAMINE; LEPTIN; NORADRENALIN; PROLACTIN;

ADOLESCENT; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BODY WEIGHT; CAUSE OF DEATH; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; EARLY DIAGNOSIS; GLASGOW COMA SCALE; HUMAN; INFANT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MENINGOCOCCEMIA; MORTALITY; MULTIPLE ORGAN FAILURE; NEUTROPHIL; PEDIATRIC RISK OF MORTALITY SCORE; PROGNOSIS; PURPURA; RASH; RISK ASSESSMENT; SCORING SYSTEM; SEPTIC SHOCK;

EID: 9644267080     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13066426     Document Type: Article

References (50)

1. Booy R, Kroll JS. Bacterial meningitis and meningococcal infection. Current Opin Pediatr 1998;10:13-8.
2. Peltola H. Early meningococcal disease: Advising the public and the profession. Lancet 1993;342:509-10.
3. Prins JM, Speelman P, Kuijper EJ, Dankert J, Deventer SJ. No increase in endotoxin release during antibiotic killing of meningococci. J Antimicrob Chemother 1997;39:13-8.
4. Sáenz-Llorens X, McCraken GH. Sepsis syndrome and sepsis shock in pediatric: current concepts of terminology, pathophysiology, and management. J Pediatr 1993;123:497-508.
5. Sinclair JF, Skeoch CH, Hallwort D. Prognosis of meningococcal septicaemia. Lancet 1987;2:38.
6. Pollack MM, Ruttimann UE, Getson PR. The Pediatric Risk of Mortality (PRISM) score. Crit Care Med 1988;16:1110-6.
7. Van Brakel MJM, Van Vught AJ, Gemke RJBJ. Pediatric risk of mortality (PRISM) score in meningococcal disease. Eur J Pediatr 2000;159:232-6.
8. Thorburn K, Baines P, Thomson A, Hart CA. Mortality in severe meningococcal disease. Arch Dis Child 2001;85:382-5.
9. Wilkinson JD, Pollack MM, Ruttimann UE, Glass NL, Yeh TS. Outcome of pediatric patients with multiple organ system failure. Crit Care Med 1986;14:271-4.
10. Algren JT, Lal S, Cutliff SA, Richman BJ. Predictors of outcome in acute meningococcal infection in childhood. Crit Care Med 1993;21:447-52.
11. Mok Q, Butt W. The outcome of children admitted to intensive care with meningococcal septicaemia. Intensive Care Med 1996;22:259-63.
12. Hatherill M, Tibby SM, Turner C, Ratnavel N, Murdoch IA. Procalcitonin and cytokine levels: Relationship to organ failure and mortality in pediatric sepsis shock. Crit Care Med 2000;28:2591-4.
13. Booy R, Habibi P, Nadel S, De Munter C, Britto J, Levin M and the Meningococcal Research Group. Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch Dis Child 2001;85:386-90.
14. Ceneviva G, Paschall A, Maffei F, Carcillo JA. Soporte hemodinámico en el shock séptico pediátrico refractario a la fluidoterapia. Pediatrics (edic esp.) 1998;102:e19.
15. Prieto Espunes S, Medina Villanueva A, Concha Torre A, Rey Galán C, Menéndez Cuervo S, Crespo Hernández M. Asistencia a los niños críticamente enfermos en Asturias: características y efectividad. An Esp Pediatr 2002;57:22-8.
16. Maruna P, Nedelnikova K, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res 2000;49:S57-S61.
17. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, et al. Procalcitonin increase after endotoxin infection in normal subjets. J Clin Endocrinol Metab 1994;93:54-8.
18. Karzai W, Oberhoffer M, Meier-Hellmann A, Reinhart K. Procalcitonin - A new indicator of the systemic response to severe infections. Infection 1997;25;329-34.
19. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-8.
20. Lorrot M, Moulin F, Coste J, Ravilly S, Guerin S, Lebon P, et al. Procalcitonin in pediatric emergency situations: comparison with C-reactive protein, interleukin-6, and alpha interferon for differentiating bacterial and viral infections. Presse Medicale 2000;29:128-34.
21. Gendrel D, Raymond J, Assicot M, Moulin F, Iñíguez JL, Lebon P, et al. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis 1997;24:1240-2.
22. García-Zarza Martínez E, Ramos Amador JT, Rubio Gribble B, Corrales del Río E, Zeballos Sarrato G, Herrera Montes J. Utilidad de la procalcitonina en en la orientación etiológica de los niños con neumonía adquirida en la comunidad. An Pediatr (Bare) 2004;60:278-9.
23. Casado Flores J, Blanco Quirós A, Asensio J, Arranz E, Garrote JA, Nieto M. Serum procalcitonin in children with suspected sepsis: A comparison with C-reactive protein and neutrophil count. Pediatr Crit Care Med 2003;4:190-5.
24. Enguix A, Rey C, Concha A, Medina A, Goto D, Diéguez MA. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med 2001;27:211-5.
25. Braithwaite SS. Procalcitonin. Marker, or mediator? Crit Care Med 1998;26:977-8.
26. Whang K, Vath S, Nylen E, Muller B, Li Q, Tamarkin L, et al. Procalcitonin and inflammatory cytokine interactions in sepsis. Shock 1999;12:268-73.
27. Moneret G, Pachot A, Laroche B, Picollet J, Bienvenu J. Procalcitonin and calcitonin gene-related peptide decrease LPS-induced TNF production by human circulating blood cells. Cytokine 2000;12:762-4.
28. Monneret C, Laroche B, Bienvenu J. Procalcitonin is not produced by circulating blood cells. Infection 1999;27:34-5.
29. Oberhoffer M, Stonans I, Russwurm S, Stonas E, Vogelsang H, Junker U, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lypopolysacharides and sepsis-related cytokines in vitro. J Lab Clin Med 1999;134:49-55.
30. Morgenthaler NG, Struck J, Chancerelle Y, Weglohner W, Agay D, Bohuon C, et al. Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection. Horm Metab Res 2003; 35:290-95.
31. Muller B, White JC, Nylen ES, Zinder RH, Becker KL, Habener JF. Ubiquitous expresión of the Calcitonin-I gene in múltiple tissue in response to sepsis J Clin Endocrinol Met 2001;86:396-404.
32. Shuldiner AR, Yang R, Gong D-W. Resistin, obesity and insulin resistance, The emerging role of the adipòcyte as an endocrine organ. N Engl J Med 2001;345:1345-6.
33. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metabol 2000;11:327-32.
34. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004;25:4-7.
35. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor.alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91.
36. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, et al. Sucutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor alpha. J Clin Endocrinol Metab 1997;82:4196-200.
37. Mohamed-Ali V, Goodrick S, Bulmer K, Holly JMP, Yudkin JS, Coppack SW. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 1999;277:E971-E975.
38. Waage A, Halstensen A, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987;I:355-7.
39. Mustafa MM, Lebel MH, Ramilo O, Olsen KD, Reisch JS, Beutler B, et al. Correlation of interleukin-1 beta and cachectin concentrations in cerebroespinal fluid and outcome from bacterial meningitis. J Pediatr 1989;115:208-13.
40. Sullivan JS, Kilpatrick L, Costarino AT, Lee SC, Harris MC. Correlation of plasma cytokine elevations with mortality rate in children with sepsis. J Pediatr 1992;120:510-5.
41. Cook DG, Mendall MA, Whincup PH, Carey IM, Ballam L, Morris JE, et al. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 2000;149;139-50.
42. Ford ES, Galuska DA, Gillespie C, Will JC, Giles WH, Dietz WH. C-reactive protein and body mass index in children: Findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Pediatr 2001;138:486-92.
43. Auwerx J, Staels S. Leptin. Lancet 1998;351:737-42.
44. Masuzaki H, Ogawa Y, Sagawa N, Hosada K, Matsumoto T, Mise H, et al. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med 1997;3:1029-33.
45. Smith-Kirwin SM, O'Connor DM, De Johnston J, Lancey DE, Hassink SG, Funanage VL. Leptin expression in human mammary epithelial cells and breast milk. J Clin Endocrinol Metab 1998;83:1810-3.
46. Arnalich F, López J, Codoceo R, Jiménez M, Madero R, Montiel C. Relationship of plasma leptin to plasma cytokines and human survival in sepsis and septic shock. J Infect Dis 1999; 180:908-11.
47. Bornstein SR, Licinio J, Tauchnitz R, Engelmann L, Negrao AB, Gold P, et al. Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab 1998;83:280-3.
48. Grunfeld C, Zhao C, Fuller J, Pollack A, Moser A, Friedman J, et al. Endotoxin and cytokine induce expresion of leptin, the ob gene product, in hamsters. A role for leptin in the anorexia of infection. J Clin Invest 1996;97:2152-7.
49. Blanco Quirós A, Casado Flores J, Arranz E, Garrote JA, Asensio J, Perez A. Influence of leptin levels and body weight in survival of children with sepsis. Acta Paediatr 2002;91:626-31.
50. Carlson GL, Saed M, Little RA, Irving MH. Serum leptin concentrations and their relation to metabolic abnormalities in human sepsis. Am J Physiol 1999;276:E658-62.